Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dorottya K de Vries

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Frontiers in Immunology|July 12, 2012
Mesenchymal stromal cells in renal ischemia/reperfusion injuryDorottya K de Vries, Alexander F M Schaapherder, Marlies E J Reinders
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 15, 2023
Endothelial to mesenchymal transition in kidney fibrosisMarleen E Jacobs, Dorottya K de Vries, Marten A Engelse, et al.
Clinical Transplantation|October 17, 2013
Donor pre-treatment in clinical kidney transplantation: a critical appraisalDorottya K de Vries, Leonie G M Wijermars, Marlies E J Reinders, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|September 14, 2012
Interleukin-9 release from human kidney grafts and its potential protective role in renal ischemia/reperfusion injuryKirsten A Kortekaas, Dorottya K de Vries, Marlies E J Reinders, et al.
Nitric Oxide : Biology and Chemistry|October 25, 2008
The L-arginine/NO pathway in end-stage liver disease and during orthotopic liver and kidney transplantation: biological and analytical ramificationsThomas Becker, Iris Mevius, Dorottya K de Vries, et al.
American Journal of Translational Research|April 12, 2018
No indications for platelet activation in acute clinical myocardial or renal ischemia/reperfusion injuryKirsten A Kortekaas, Dorottya K de Vries, Mark Roest, et al.
Transplantation|January 26, 2013
Acute but transient release of terminal complement complex after reperfusion in clinical kidney transplantationDorottya K de Vries, Pieter van der Pol, Gerritje E van Anken, et al.
American Journal of Physiology. Renal Physiology|December 30, 2016
The hypoxanthine-xanthine oxidase axis is not involved in the initial phase of clinical transplantation-related ischemia-reperfusion injuryLeonie G M Wijermars, Jaap A Bakker, Dorottya K de Vries, et al.
Biochimica Et Biophysica Acta. Bioenergetics|January 19, 2025
Clinical ischemia-reperfusion injury: Driven by reductive rather than oxidative stress? A narrative reviewMichèle J C de Kok, Alexander F M Schaapherder, Jonna R Bloeme-Ter Horst, et al.
Microrna (Shariqah, United Arab Emirates)|December 27, 2014
Silencing of miRNA-126 in kidney ischemia reperfusion is associated with elevated SDF-1 levels and mobilization of Sca-1+/Lin- progenitor cellsRoel Bijkerk, Coen van Solingen, Hetty C de Boer, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Frontiers in Immunology|July 12, 2012
Mesenchymal stromal cells in renal ischemia/reperfusion injuryDorottya K de Vries, Alexander F M Schaapherder, Marlies E J Reinders
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 15, 2023
Endothelial to mesenchymal transition in kidney fibrosisMarleen E Jacobs, Dorottya K de Vries, Marten A Engelse, et al.
Clinical Transplantation|October 17, 2013
Donor pre-treatment in clinical kidney transplantation: a critical appraisalDorottya K de Vries, Leonie G M Wijermars, Marlies E J Reinders, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|September 14, 2012
Interleukin-9 release from human kidney grafts and its potential protective role in renal ischemia/reperfusion injuryKirsten A Kortekaas, Dorottya K de Vries, Marlies E J Reinders, et al.
Nitric Oxide : Biology and Chemistry|October 25, 2008
The L-arginine/NO pathway in end-stage liver disease and during orthotopic liver and kidney transplantation: biological and analytical ramificationsThomas Becker, Iris Mevius, Dorottya K de Vries, et al.
American Journal of Translational Research|April 12, 2018
No indications for platelet activation in acute clinical myocardial or renal ischemia/reperfusion injuryKirsten A Kortekaas, Dorottya K de Vries, Mark Roest, et al.
Transplantation|January 26, 2013
Acute but transient release of terminal complement complex after reperfusion in clinical kidney transplantationDorottya K de Vries, Pieter van der Pol, Gerritje E van Anken, et al.
American Journal of Physiology. Renal Physiology|December 30, 2016
The hypoxanthine-xanthine oxidase axis is not involved in the initial phase of clinical transplantation-related ischemia-reperfusion injuryLeonie G M Wijermars, Jaap A Bakker, Dorottya K de Vries, et al.
Biochimica Et Biophysica Acta. Bioenergetics|January 19, 2025
Clinical ischemia-reperfusion injury: Driven by reductive rather than oxidative stress? A narrative reviewMichèle J C de Kok, Alexander F M Schaapherder, Jonna R Bloeme-Ter Horst, et al.
Microrna (Shariqah, United Arab Emirates)|December 27, 2014
Silencing of miRNA-126 in kidney ischemia reperfusion is associated with elevated SDF-1 levels and mobilization of Sca-1+/Lin- progenitor cellsRoel Bijkerk, Coen van Solingen, Hetty C de Boer, et al.
Pageof 4